Grazoprevir-话题@MedSci - 梅斯（MedSci）

#Grazoprevir#

8篇内容 | 1131人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1650079, encodeId=2cd816500e947, content=<a href='/topic/show?id=1ede8252ab' target=_blank style='color:#2F92EE;'>#Grazoprevir#</a>, objectTitle=AIM：接受阿片类药物激动剂治疗的HCV患者使用elbasvir-grazoprevir治疗的SVR12较高, objectType=article, longId=74873, objectId=3233e487368, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3233e487368, replyNumber=0, likeNumber=81, createdTime=2017-06-18, rootId=0, userName=zgwhgch, userId=a76f23955752, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3233e487368, moduleTitle=AIM：接受阿片类药物激动剂治疗的HCV患者使用elbasvir-grazoprevir治疗的SVR12较高, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=3233e487368)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1650081, encodeId=25e8165008133, content=<a href='/topic/show?id=1ede8252ab' target=_blank style='color:#2F92EE;'>#Grazoprevir#</a>, objectTitle=J Gastroenterol：日本人群中Elbasvir 联合grazoprevir 治疗HCV：II/III期临床研究, objectType=article, longId=93569, objectId=376693569b4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=376693569b4, replyNumber=0, likeNumber=75, createdTime=2017-06-01, rootId=0, userName=zgwhgch, userId=a76f23955752, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=376693569b4, moduleTitle=J Gastroenterol：日本人群中Elbasvir 联合grazoprevir 治疗HCV：II/III期临床研究, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=376693569b4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1650080, encodeId=9a3816500802b, content=<a href='/topic/show?id=1ede8252ab' target=_blank style='color:#2F92EE;'>#Grazoprevir#</a>, objectTitle=2016NICE技术评估指南：Elbasvir–grazoprevir用于治疗慢性丙型肝炎（TA413）发布, objectType=article, longId=81113, objectId=42e58111305, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=42e58111305, replyNumber=0, likeNumber=67, createdTime=2016-10-30, rootId=0, userName=zgwhgch, userId=a76f23955752, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=42e58111305, moduleTitle=2016NICE技术评估指南：Elbasvir–grazoprevir用于治疗慢性丙型肝炎（TA413）发布, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=42e58111305)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1650078, encodeId=51d816500e83a, content=<a href='/topic/show?id=1ede8252ab' target=_blank style='color:#2F92EE;'>#Grazoprevir#</a>, objectTitle=2016国际肝病会议：治疗基因型1型和4型HCV感染，Elbasvir/grazoprevir方案的安全性和疗效性更优, objectType=article, longId=66791, objectId=ff0366e9153, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ff0366e9153, replyNumber=0, likeNumber=79, createdTime=2017-04-01, rootId=0, userName=zgwhgch, userId=a76f23955752, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ff0366e9153, moduleTitle=2016国际肝病会议：治疗基因型1型和4型HCV感染，Elbasvir/grazoprevir方案的安全性和疗效性更优, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=ff0366e9153)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1650076, encodeId=9a9b16500e6f7, content=<a href='/topic/show?id=1ede8252ab' target=_blank style='color:#2F92EE;'>#Grazoprevir#</a>, objectTitle=AIM：Grazoprevir和Elbasvir的新组合方案为HCV感染者提供了新的治疗选择, objectType=article, longId=53210, objectId=e67d53210e4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e67d53210e4, replyNumber=0, likeNumber=74, createdTime=2016-05-04, rootId=0, userName=zgwhgch, userId=a76f23955752, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e67d53210e4, moduleTitle=AIM：Grazoprevir和Elbasvir的新组合方案为HCV感染者提供了新的治疗选择, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=e67d53210e4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1650077, encodeId=932b16500e7c3, content=<a href='/topic/show?id=1ede8252ab' target=_blank style='color:#2F92EE;'>#Grazoprevir#</a>, objectTitle=Lancet：4-5期慢性肾病患者感染HCV治疗：grazoprevir和elbasvir效果良好, objectType=article, longId=57067, objectId=fde15e0670c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fde15e0670c, replyNumber=0, likeNumber=73, createdTime=2016-07-06, rootId=0, userName=zgwhgch, userId=a76f23955752, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fde15e0670c, moduleTitle=Lancet：4-5期慢性肾病患者感染HCV治疗：grazoprevir和elbasvir效果良好, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=fde15e0670c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1650075, encodeId=65a016500e5c9, content=<a href='/topic/show?id=1ede8252ab' target=_blank style='color:#2F92EE;'>#Grazoprevir#</a>, objectTitle=Lancet HIV：Grazoprevir加Elbasvir可有效治疗HIV和HCV共感染的患者, objectType=article, longId=53180, objectId=16e6531804a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=16e6531804a, replyNumber=0, likeNumber=77, createdTime=2016-02-04, rootId=0, userName=zgwhgch, userId=a76f23955752, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=16e6531804a, moduleTitle=Lancet HIV：Grazoprevir加Elbasvir可有效治疗HIV和HCV共感染的患者, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=16e6531804a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1650074, encodeId=4b7916500e428, content=<a href='/topic/show?id=1ede8252ab' target=_blank style='color:#2F92EE;'>#Grazoprevir#</a>, objectTitle=AIM：Grazoprevir-Elbasvir联合对慢性丙肝（HCV）治疗抵抗患者有显著效果, objectType=article, longId=49877, objectId=9697498e729, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9697498e729, replyNumber=0, likeNumber=94, createdTime=2015-11-25, rootId=0, userName=zgwhgch, userId=a76f23955752, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9697498e729, moduleTitle=AIM：Grazoprevir-Elbasvir联合对慢性丙肝（HCV）治疗抵抗患者有显著效果, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=9697498e729)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

Grazoprevir

2020-05-29

zgwhgch (审核中...)

前往app查看评论内容

#Grazoprevir#

AIM：接受阿片类药物激动剂治疗的HCV患者使用elbasvir-grazoprevir治疗的SVR12较高

2017-06-18

zgwhgch (审核中...)

前往app查看评论内容

#Grazoprevir#

J Gastroenterol：日本人群中Elbasvir 联合grazoprevir 治疗HCV：II/III期临床研究

2017-06-01

zgwhgch (审核中...)

前往app查看评论内容

#Grazoprevir#

2016NICE技术评估指南：Elbasvir–grazoprevir用于治疗慢性丙型肝炎（TA413）发布

2016-10-30

zgwhgch (审核中...)

前往app查看评论内容

#Grazoprevir#

2016国际肝病会议：治疗基因型1型和4型HCV感染，Elbasvir/grazoprevir方案的安全性和疗效性更优

2017-04-01

zgwhgch (审核中...)

前往app查看评论内容

#Grazoprevir#

AIM：Grazoprevir和Elbasvir的新组合方案为HCV感染者提供了新的治疗选择

2016-05-04

zgwhgch (审核中...)

前往app查看评论内容

#Grazoprevir#

Lancet：4-5期慢性肾病患者感染HCV治疗：grazoprevir和elbasvir效果良好

2016-07-06

zgwhgch (审核中...)

前往app查看评论内容

#Grazoprevir#

Lancet HIV：Grazoprevir加Elbasvir可有效治疗HIV和HCV共感染的患者

2016-02-04

zgwhgch (审核中...)

前往app查看评论内容

#Grazoprevir#

AIM：Grazoprevir-Elbasvir联合对慢性丙肝（HCV）治疗抵抗患者有显著效果

2015-11-25

科室
- - 订阅+
  - 更多科室
工具
服务